8/15/2023 0 Comments Orbis research music produciton![]() ![]() Google can bring you back 100,000 answers. The core of ORBIS is constituted by international, intersectoral exchange of researchers between academic centres and pharmaceutical companies – the consortium partners.ĭuring the secondments planned in the project, young and experienced scientists will cooperate with the hosting institutions on the most relevant and up-to-date issues of drug development process, such as: synthesis and optimisation of new active ingredients, preformulation studies, development of novel oral, dermal and transdermal dosage forms, as well as their biopharmaceutical evaluation with new analytical methods. This goal can be achieved by interdisciplinary cooperation between the academics from different fields of pharmaceutical sciences and the employees of R&D sector in commercial enterprises. The ORBIS Project is a response to the current scientific, economic and social challenge of increasing the effectiveness and productivity of drug development process, both for innovative and (super)generic drugs. (Czech Republic), Poznan University of Technology (Poland), University of Chemistry and Technology Prague (Czech Republic), University of Ljubljana (Slovenia), University of Central Florida (USA), Celon Pharma (Poland), and Rutgers University (USA). (Ireland), Farmak JSC (Ukraine), Physiolution GmbH (Germany), Zentiva k.s. Among our consortium partners are: Poznan University of Medical Sciences (Poland), Trinity College Dublin (Ireland), University of Helsinki (Finland), Applied Process Company Ltd. Janina Lulek of the Department of Pharmaceutical Technology at PUMS Faculty of Pharmacy. ![]() 8 academies and 5 pharmaceutical companies from 8 countries participate in the ORBIS project, which is coordinated by Prof. ![]() This is a great success for Poznan University of Medical Sciences in particular since for the first time the Faculty of Pharmacy of our university will be the consortium leader for 9 academic and commercial institutions from Europe and the USA in a research project of such broad scale, impact and prestige. The four-year-long (2018-2022) grant was favourably evaluated in the Research and Innovation Staff Exchange (RISE) call under the Maria Skłodowska-Curie Actions of Horizon 2020 Framework Programme (H2020-MSCA-RISE-2017). 778051 entitled ORBIS (Open Research Biopharmaceutical Internships Support) has begun. We are happy and proud to announce that on 1st March 2018 the realisation of a prestigious, international and intersectoral project no. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |